ARCHIVES

FDA Approves Cyramza for Stomach Cancer; Zykadia in NSCLC; Lipiodol for HCC Imaging; And Cobas HPV Test for Primary Screening

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Bypass Budget Calls For $5.98 Billion

December 6, 2002

House Still Sees Problems In NIH Financial Management

July 5, 1991

DCT Planning To Stop Use Monkeys In Preclinical Test

November 17, 1978

Central Oncology Group Phase Out Approved; Board Impressed By Unanimous CCIRC Vote

April 2, 1976

Q & A With Shannon Brownlee: Task Force Independence at Stake In Debate over PSA Screening

October 6, 2011

New Patterns Of Care Study Okayed By DCT Board

June 13, 1986